Filter announcements
Loading...
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.
AstraZeneca Pharma India Ltd has announced a board meeting regarding its financial results for the quarter ended December 31, 2024. The company reported total revenue from operations of ₹4,402.9 million, reflecting a 44% increase year-over-year. Profit after tax was ₹308.5 million, impacted by exceptional items, including significant restructuring costs related...